The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome)
- PMID: 4011844
The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome)
Abstract
The aetiology, clinical features and outcome of 40 patients presenting with Goodpasture's syndrome (glomerulonephritis with haemoptysis and pulmonary infiltrates) are reviewed. The diseases of the patients studied could be divided into three groups: antiglomerular basement membrane (anti-GBM) antibody-induced disease (7/40); systemic vasculitis (22/40) and idiopathic Goodpasture's syndrome (i.e. no systemic disease or anti-GBM antibody detected) (11/40). Overall mortality was 57.5 per cent (anti-GBM disease 4/7; systemic vasculitis 15/22; and idiopathic Goodpasture's syndrome 4/11). Most patients died of disease progression or infection. End-stage renal failure developed in 26 patients (anti-GBM (7), vasculitis (14) and idiopathic Goodpasture's syndrome (5). End-stage renal failure developed in 23 of 24 patients presenting with a creatinine of greater than 600 microM/l regardless of the aetiology of Goodpasture's syndrome or treatment used. Review of renal histology showed that all had proliferative nephritis, with 80 per cent of patients having more than 30 per cent crescents. Thus Goodpasture's syndrome was associated with a wide variety of underlying disease. It had a poor prognosis, with the degree of renal impairment at presentation, the extent of crescent formation and the nature of the underlying disease being the major determinants of outcome.
Similar articles
-
The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.J Pathol. 2003 May;200(1):118-29. doi: 10.1002/path.1336. J Pathol. 2003. PMID: 12692850
-
Goodpasture's syndrome associated with pulmonary eosinophilic vasculitis.J Rheumatol. 1988 Aug;15(8):1298-301. J Rheumatol. 1988. PMID: 3184080
-
Vasculitis in Goodpasture's syndrome.Arch Pathol Lab Med. 1980 Jun;104(6):300-2. Arch Pathol Lab Med. 1980. PMID: 6892868
-
Characteristics and outcomes of patients with Goodpasture's syndrome.South Med J. 2002 Dec;95(12):1411-8. South Med J. 2002. PMID: 12597309 Review.
-
Diagnosis and classification of Goodpasture's disease (anti-GBM).J Autoimmun. 2014 Feb-Mar;48-49:108-12. doi: 10.1016/j.jaut.2014.01.024. Epub 2014 Jan 21. J Autoimmun. 2014. PMID: 24456936 Review.
Cited by
-
Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.J Clin Immunol. 1991 Jul;11(4):161-74. doi: 10.1007/BF00917422. J Clin Immunol. 1991. PMID: 1918264 Review.
-
Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases.Front Endocrinol (Lausanne). 2021 Apr 23;12:641635. doi: 10.3389/fendo.2021.641635. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33967957 Free PMC article.
-
Relapse of idiopathic pulmonary haemorrhage and glomerulonephritis associated with cytomegalovirus (CMV) infection.Postgrad Med J. 1988 Jan;64(747):52-5. doi: 10.1136/pgmj.64.747.52. Postgrad Med J. 1988. PMID: 2843844 Free PMC article.
-
Suppression of pulmonary injury in experimental 'Goodpasture's syndrome' by deoxyspergualin (DSP).Clin Exp Immunol. 1994 Mar;95(3):502-8. doi: 10.1111/j.1365-2249.1994.tb07026.x. Clin Exp Immunol. 1994. PMID: 8137546 Free PMC article.